Cargando…
Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
Despite significant progress in the development of treatment options, melanoma remains a leading cause of death due to skin cancer. Advances in our understanding of the genetic, transcriptomic, and morphologic spectrum of benign and malignant melanocytic neoplasia have enabled the field to propose b...
Autores principales: | Deacon, Dekker C., Smith, Eric A., Judson-Torres, Robert L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085270/ https://www.ncbi.nlm.nih.gov/pubmed/33937286 http://dx.doi.org/10.3389/fmed.2021.642380 |
Ejemplares similares
-
Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects
por: Kraaijvanger, Raisa, et al.
Publicado: (2020) -
Current Trends in Circulating Biomarkers for Melanoma Detection
por: Huang, Nancy, et al.
Publicado: (2022) -
Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects
por: Pilla, Lorenzo, et al.
Publicado: (2020) -
Extrachromosomal circular DNA: Current status and future prospects
por: Zhao, Yiheng, et al.
Publicado: (2022) -
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives
por: Aramayo-Singelmann, Carmen, et al.
Publicado: (2022)